title: [Does the treatment focused on controlling the activity of the underlying inflammatory disease and reducing the serum level of AA protein improve the prognosis of systemic amyloidosis?].
authors.affiliation: Servicio de Nefrología, Hospital Infanta Sofia, Madrid, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Barrio
authors.forename: F
authors.initials: F
authors.lastname: Ortiz-Herbener